Abstract: The present invention pertains generally to the field of therapy. More specifically the present invention pertains to a certain compound, [((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester (also referred to herein as “AX-8” or “Gly-O-iPr”), as described herein, for use in a method of treatment of the human or animal body by therapy, more specifically, for use in a method of treatment of chronic cough (CC), including, for example, refractory chronic cough (RCC) and idiopathic chronic cough (ICC), as described herein.

Abstract: A method for generating output data identifying a class of a predetermined plurality of classes. The method comprises receiving data representing an acoustic signal; determining an amplitude of at least a first predetermined frequency component of said acoustic signal; and comparing the or each amplitude with a respective primary threshold; and generating output data identifying one of said classes to which said acoustic signal should be allocated, based upon said comparison.

Abstract: A bedding system for use where mite-allergy is a problem causing e.g. asthma comprises a permeable mite barrier such as microporous or vapor permeable coated fabric which can be used as a mattress cover or ticking, pillow and duvet covers.